Lv0
0 积分 2026-07-25 加入
Liver injury related to vascular endothelial growth factor tyrosine kinase inhibitors: a pharmacovigilance analysis of the USA FDA adverse event reporting system (FAERS) database
7天前
已完结
A systematic review on clinical pharmacokinetics and pharmacodynamics of antiangiogenic tyrosine kinase inhibitors (TKIs) with high TDM scores
7天前
已完结
Comparison of Lanreotide and Octreotide LAR Use and Outcomes for Gastrointestinal Neuroendocrine Tumors in British Columbia, Canada
7天前
已完结
Initial real-world experience with ribociclib in advanced breast cancer
8天前
已关闭
Aromatase inhibitors and medication-related osteonecrosis of the jaw: Friends, foes, or bystanders?
8天前
已关闭
Body mass index in postmenopausal women with estrogen receptor-positive, HER2-negative early breast cancer: An exploratory analysis of the LORELEI trial
8天前
已关闭
CYP3A4‐Mediated Metabolism and Drug–Drug Interaction Potential of Abemaciclib and Letrozole In Vitro
8天前
已关闭
Spatially resolved transcriptomics identifies tumor-stroma-immune networks and therapeutic targets in endocrine-resistant advanced breast cancer treated with Everolimus+Letrozole: insights from the MIRACLE trial
9天前
已完结
Abstract RF1-02: Palbociclib plus letrozole versus weekly paclitaxel, both in combination w/ trastuzumab plus pertuzumab, as neoadjuvant treatment for patients w/ HR+/HER2+ early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17)
9天前
已完结
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial
13天前
已完结
皖公网安备34019202002308
